{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T09:16:10Z","timestamp":1761988570499},"reference-count":10,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diabetes & Metabolic Syndrome: Clinical Research & Reviews"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1016\/j.dsx.2013.02.028","type":"journal-article","created":{"date-parts":[[2013,3,9]],"date-time":"2013-03-09T05:35:28Z","timestamp":1362807328000},"page":"1-2","source":"Crossref","is-referenced-by-count":11,"title":["Botulinum toxin for meralgia paresthetica in type 2 diabetes"],"prefix":"10.1016","volume":"7","author":[{"given":"Pawan","family":"Dhull","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.K.","family":"Tewari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vimal","family":"Upreti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.S.","family":"Prakash","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.V.S.","family":"Hari Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.dsx.2013.02.028_bib0005","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1089\/dia.2010.0069","article-title":"Risk factors for microvascular complications of diabetes among South Indian subjects with type 2 diabetes \u2013 the Chennai Urban Rural Epidemiology Study (CURES) Eye Study-5","volume":"12","author":"Pradeepa","year":"2010","journal-title":"Diabetes Technology and Therapeutics"},{"key":"10.1016\/j.dsx.2013.02.028_bib0010","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.pain.2008.01.006","article-title":"Neuropathic pain: are there distinct subtypes depending on the aetiology or anatomical lesion?","volume":"138","author":"Attal","year":"2008","journal-title":"Pain"},{"key":"10.1016\/j.dsx.2013.02.028_bib0015","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.pain.2007.08.033","article-title":"Pharmacologic management of neuropathic pain: evidence-based recommendations","volume":"132","author":"Dworkin","year":"2007","journal-title":"Pain"},{"key":"10.1016\/j.dsx.2013.02.028_bib0020","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1007\/s00415-004-0310-x","article-title":"Incidence rates and determinants in meralgia paresthetica in general practice","volume":"251","author":"van Slobbe","year":"2004","journal-title":"Journal of Neurology"},{"key":"10.1016\/j.dsx.2013.02.028_bib0025","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1111\/j.1526-4637.2006.00227.x","article-title":"Meralgia paresthetica: diagnosis and management strategies","volume":"8","author":"Harney","year":"2007","journal-title":"Pain Medicine"},{"key":"10.1016\/j.dsx.2013.02.028_bib0030","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1212\/01.wnl.0000345968.05959.cf","article-title":"Botulinum toxin for diabetic neuropathic pain: a randomized double-blind crossover trial","volume":"72","author":"Yuan","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.dsx.2013.02.028_bib0035","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1212\/01.wnl.0000180940.98815.74","article-title":"An open study of botulinum A toxin treatment of trigeminal neuralgia","volume":"65","author":"Piovesan","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.dsx.2013.02.028_bib0040","doi-asserted-by":"crossref","first-page":"511","DOI":"10.2165\/00044011-200626090-00004","article-title":"Efficacy of botulinum toxin type A in the relief of carpal tunnel syndrome: a preliminary experience","volume":"26","author":"Tsai","year":"2006","journal-title":"Clinical Drug Investigation"},{"key":"10.1016\/j.dsx.2013.02.028_bib0045","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1002\/ana.21427","article-title":"Botulinum toxin type A induces direct analgesic effects in chronic neuropathic pain","volume":"64","author":"Ranoux","year":"2008","journal-title":"Annals of Neurology"},{"key":"10.1016\/j.dsx.2013.02.028_bib0050","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1002\/mus.10080","article-title":"Diabetic and nondiabetic lumbosacral radiculoplexus neuropathies: new insights into pathophysiology and treatment","volume":"25","author":"Dyck","year":"2002","journal-title":"Muscle and Nerve"}],"container-title":["Diabetes & Metabolic Syndrome: Clinical Research & Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871402113000295?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871402113000295?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,18]],"date-time":"2018-10-18T05:25:03Z","timestamp":1539840303000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1871402113000295"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":10,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["S1871402113000295"],"URL":"https:\/\/doi.org\/10.1016\/j.dsx.2013.02.028","relation":{},"ISSN":["1871-4021"],"issn-type":[{"value":"1871-4021","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1]]}}}